Hoverink Biotechnologies Inc (none)

Not featured in screeners

Not featured in screeners

Ticker: none

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

McKillop James K

frmer officer, director, 10%sh

1 sale — total 9,506,250,000 USD

Sale 15 Feb 2015

Value US$4,303,847.56 | Price 70.81 | Shares 30,613

CASSIDY JAMES M

frmer officer, director, 10%sh

1 sale — total 9,506,250,000 USD

Sale 15 Feb 2015

Value US$2,312,947.40 | Price 240.01 | Shares 45,905

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2015-08-26	2015-02-15	S Sale	McKillop James K frmer officer, director, 10%sh	30,613 -17.4% 70.81 US$4,303,848	30,613 -17.4%	70.81	US$4,303,848
2015-08-26	2015-02-15	S Sale	CASSIDY JAMES M frmer officer, director, 10%sh	45,905 +12.6% 240.01 US$2,312,947	45,905 +12.6%	240.01	US$2,312,947

More insider trading research around Hoverink Biotechnologies Inc